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using pharmacological manipulations of GABA signaling, such as 
fluoxetine, to reinstate ocular dominance plasticity in adult visual 
cortex and facilitate recovery from amblyopia (Maya Vetencourt 
et al., 2008; Harauzov et al., 2010). Taken together, these studies 
are providing a better understanding for the role of GABAergic 
signaling in the maturation and function of the visual cortex, and 
have opened the door for the development of new treatments for 
neurodevelopmental disorders such as amblyopia.
The GABAergic synapse is a complex structure with a large set 
of pre- and post-synaptic proteins, many of which have been linked 
with experience-dependent plasticity in the cortex. On the pre-syn-
aptic side these include: the two isoforms of the GABA synthesizing 
enzyme glutamic acid decarboxylase (GAD), GAD65 and GAD67; 
the CB1 receptor that modulates GABA release; and the vesicular 
transporter VGAT that is responsible for loading GABA into syn-
aptic vesicles (McIntire et al., 1997; Sagne et al., 1997). GAD65 is 
localized in the axon terminals and synthesizes the on-demand pool 
of GABA, while GAD67 is located in the cell body and synthesizes 
the basal pool of GABA (Feldblum et al., 1993, 1995). Knocking 
out GAD65 leads to a loss of critical period ocular dominance 
plasticity, however, it can be rescued by infusion of diazepam (Iwai 
et al., 2003). Activation of CB1 receptors is involved in regulating 
activity-dependent synaptic plasticity (Sjöström et al., 2003; Jiang 
IntroductIon
Functional maturation of the visual cortex is linked with dynamic 
changes in synaptic expression of GABAergic signaling mecha-
nisms. Even small changes in the relative amounts of excitation 
and inhibition can dramatically alter experience-dependent plas-
ticity (Kirkwood and Bear, 1994; Hensch et al., 1998; Iwai et al., 
2003). During development, specific components of the GABAergic 
signaling affect ocular dominance plasticity (Hensch et al., 1998; 
Fagiolini et al., 2004; Hensch, 2005) and orientation selectivity 
(Tsumoto and Sato, 1985; Fagiolini et al., 2004). Furthermore, 
the emergence of normal binocular visual function depends on 
interocular inhibition that is mediated by GABAergic inhibitory 
circuitry in visual cortex (Sengpiel and Vorobyov, 2005). In adult 
visual cortex, activity regulates GABAA receptor expression (Hendry 
et al., 1994) and during aging the loss of orientation tuning in 
visual cortical receptive fields (Leventhal et al., 2003) and changes 
in visual perception (Betts et al., 2005) have been linked with an 
overall loss of GABA.
When GABAergic signaling in visual cortex is manipulated to 
shift the excitatory-inhibitory balance, the effect can either enhance 
or reduce experience-dependent plasticity (Kirkwood and Bear, 
1994; Iwai et al., 2003; Maffei et al., 2004; Hensch and Fagiolini, 
2005). This approach has been extended in a series of recent studies 
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et al., 2010) and blocking CB1 receptors during the critical period 
alters activity patterns (Bernard et al., 2005). Finally, VGAT con-
tributes to an efficient up- and down-regulation of vesicular GABA 
content that effects post-synaptic currents and the fine-tuning of 
inhibitory strength (Engel et al., 2001).
On the post-synaptic side many components of the ionotropic 
GABAA receptor complex contribute to experience-dependent plas-
ticity. Gephyrin is the GABAA receptor anchoring protein. Gephyrin 
clusters GABAA receptors (Essrich et al., 1998; Kneussel et al., 1999), 
and it seems to fulfill a modulator role for changes in synaptic 
activity and structure. Furthermore, expression levels of Gephyrin 
give an indication of the total amount of GABAA receptors at a 
given time. The GABAA receptor is a pentameric structure and is 
functionally diverse, with 20 known subunits. Three subunits are 
of particular interest, α1, α2, and α3, because they are develop-
mentally regulated (Hendrickson et al., 1994; Chen et al., 2001; 
Bosman et al., 2002), they affect receptor kinetics (Laurie et al., 
1992; Gingrich et al., 1995), and the α subunit is the interface for 
binding GABA (Smith and Olsen, 1995) and benzodiazepine (Sigel, 
2002). Both α1 and α2 subunits play key functional roles, with 
α2 involved in regulating cell firing, and α1 necessary for criti-
cal period plasticity (Fagiolini et al., 2004). The α1 subunit also 
has high-affinity for binding GABA and benzodiazepine receptor 
ligands (Pritchett et al., 1989).
Although there have been many animal studies of develop-
mental and aging changes in expression of GABAergic signaling 
components in visual cortex (e.g., Shaw et al., 1991; Hendrickson 
et al., 1994; Hornung and Fritschy, 1996; Guo et al., 1997; Leventhal 
et al., 2003; Minelli et al., 2003), there have been relatively few 
studies of human visual cortex (Murphy et al., 2005). This poses 
a challenge when considering how to translate GABAergic drug 
treatments for amblyopia from animal models to human trials. 
To fill this gap, we have carried out a comprehensive study of 
changes in the expression of a collection of pre- and post-synaptic 
GABAergic signaling mechanisms in human visual cortex across 
the lifespan. Using Western blot analysis we quantified the devel-
opmental trajectories for four pre- and four post-synaptic com-
ponents of GABA signaling. These results show a complex pattern 
of different developmental trajectories among the GABA signaling 
mechanisms in human visual cortex. Many of the changes are 
prolonged, highlighting a long time course for the development 
of GABA signaling in human visual cortex, much longer than 
would be predicted from animal studies. Furthermore, there are 
three transition stages when there are rapid switches in the relative 
amounts of the different components, indicating that functioning 
of the GABAergic system must change as the visual cortex develops 
and ages. A portion of these data has been presented previously 
(Pinto et al., 2008).
MaterIals and Methods
saMples and tIssue
Tissue samples were obtained from the Brain and Tissue Bank for 
Developmental Disorders at the University of Maryland (Baltimore, 
MD, USA). The samples were from the posterior pole of the left 
hemisphere of human visual cortex, including both superior and 
inferior portions of the calcarine fissure where the central visual 
field is represented in primary visual cortex (V1) according to the 
gyral and sulcal landmarks. The samples were from 28 individuals 
ranging in age from 20 days to 80 years (Table 1). All samples were 
obtained within 23 h postmortem, and at the Brain and Tissue Bank 
were fresh frozen after being sectioned coronally in 1-cm intervals, 
rinsed with water, blotted dry, placed in a quick-freeze bath (dry ice 
and isopentane), and stored frozen (−70°C). The individuals had 
no history of neurological or mental health disorders.
Table 1 | Human tissue samples. The age group, age, postmortem interval 
and cause of death for each of the human cortical tissue samples.
Age group  Age  Postmortem  Sex  Cause of death 
    interval (hours)
Neonates  20 days  14  F  Pneumonia
Neonates  86 days  23  F  Not known
Neonates  96 days  12  M  Bronchopneumonia
Neonates  98 days  16  M  Cardiovascular 
        disorder
Neonates  119 days  22  M  Bronchopneumonia
Neonates  120 days  23  M  Pneumonia
Neonates  133 days  16  M  Accidental
Neonates  136 days  11  F  Pneumonia
Neonates  273 days  10  M  Sudden infant 
        death syndrome
Infants  1.34 years  21  M  Dehydration
Infants  2.16 years  21  F  Cardiovascular 
        disorder
Infants  2.21 years  11  F  Accidental
Young  3.34 years  11  F  Drowning 
children
Young  4.56 years  15  M  Accidental 
children
Young  4.71 years  17  M  Drowning 
children
Older  5.40 years  17  M  Accidental 
children
Older  8.14 years  20  F  Accidental 
children
Older  8.59 years  20  F  Cardiovascular 
children        disorder
Teens  12.45 years  22  M  Cardiovascular 
        disorder
Teens  13.27 years  5  M  Asphyxia
Teens  15.22 years  16  M  Multiple injuries
Young adults  22.98 years  4  M  Multiple injuries
Young adults  32.61 years  13  M  Cardiovascular 
        disorder
Young adults  50.43 years  8  M  Cardiovascular 
        disorder
Young adults  53.90 years  5  F  Cardiovascular 
        disorder
Older adults  69.30 years  12  M  Cardiovascular 
        disorder
Older adults  71.91 years  9  F  Multiple medical 
        disorders
Older adults  79.50 years  14  F  Drug overdoseFrontiers in Cellular Neuroscience  www.frontiersin.org  June 2010  | Volume 4  | Article 16  |  3
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tIssue saMple preparatIon
Tissue samples (50–100 mg) were cut from the frozen block of V1 
and suspended in cold homogenization buffer (1 ml buffer:50 mg 
tissue, 0.5 mM DTT, 1 mM EDTA, 2 mM EGTA, 10 mM HEPES, 
10 mg/L leupeptin, 100 nM microcystin, 0.1 mM PMSF, 50 mg/L 
soybean trypsin inhibitor). The tissue samples were homogenized 
in a glass-glass Dounce homogenizer (Kontes, Vineland, NJ, USA). 
A  subcellular  fractionation  procedure  (synaptoneurosomes) 
(Hollingsworth et al., 1985; Titulaer and Ghijsen, 1997; Quinlan 
et al., 1999) was performed to obtain protein samples that were 
enriched for synaptic proteins. The synaptoneurosome was obtained 
by passing the homogenized sample through a coarse (100 μm) pore 
nylon-mesh filter followed by a fine (5 μm) pore hydrophilic mesh 
filter (Millipore, Bedford, MA, USA), then centrifuged at 1000 × g 
for 10 min to obtain the synaptic fraction of the membrane. The syn-
aptic pellet was resuspended in boiling 1% sodium-dodecyl-sulfate 
(SDS) and stored at −80°C. Protein concentrations were determined 
using the bicinchonic acid (BCA) assay guidelines (Pierce, Rockford, 
IL, USA). A control sample was made by combining a small amount 
of the prepared tissue sample from each of the cases.
IMMunoblottIng
The samples (20 μg) were separated on sodium-dodecyl-sulfate 
polyacrylamide gels (SDS-PAGE) and transferred to polyvinylidene 
difluoride (PVDF-FL) membranes (Millipore, Billerica, MA, USA). 
Each sample was run multiple times. Blots were pre-incubated in 
blocking buffer [Odyssey Blocking Buffer 1:1 with phosphate buff-
ered saline (PBS)] for 1 h (LI-COR Biosciences; Lincoln, NE, USA), 
then incubated in primary antibody overnight at 4°C using the 
following concentrations: GAD65, 1:500 (Chemicon International, 
Temecula, CA, USA); GAD67, 1:1000 (Chemicon International, 
Temecula, CA, USA); VGAT, 1:1000 (Synaptic Systems, Göttingen, 
Germany); CB1, 1:1000 (Cayman, Ann Arbor, MI, USA); Gephyrin, 
1:500 (Chemicon International, Temecula, CA, USA); GABAAα1, 
1:500 (Imgenex, San Diego, CA, USA); GABAAα2, 1:1000 (Imgenex, 
San Diego, CA, USA); GABAAα3, 1:1000 (Imgenex, San Diego, CA, 
USA). The blots were washed with PBS containing 0.05% Tween 
(PBS-T, Sigma, St. Louis, MO, USA) (3 × 10 min), incubated (1 h, 
room temperature) with the appropriate IRDye labeled secondary 
antibody, (Anti-Mouse, 1:8000, Anti-Rabbit, 1:10,000) (LI-COR 
Biosciences; Lincoln, NE, USA), and washed in PBS-T (3 × 10 min). 
The blots were visualized using the Odyssey scanner (LI-COR 
Biosciences; Lincoln, NE). The blots were stripped and prepared 
to be re-probed with additional antibodies (Blot Restore Membrane 
Rejuvenation kit, Chemicon International, Temecula, CA, USA).
analysIs
To analyze the bands, we scanned the blots (Odyssey Infrared 
Scanner) and quantified the bands using densitometry (LI-COR 
Odyssey Software version 3.0; LI-COR Biosciences; Lincoln, NE, 
USA). Density profiles were determined by performing a subtrac-
tion of the background, integrating the pixel intensity across the 
area of the band, and dividing the intensity by the width of the 
band to control for variations in band size. A control sample (a 
mixture of all the samples) was run on all of the gels and the den-
sity of each sample was measured relative to that control (sample 
density/control density).
To visualize changes in expression of the GABAergic signaling 
mechanisms, the results were plotted in two ways. This was done 
to facilitate analysis of changes between developmental stages, to 
describe the pattern of changes, and to be able to quantify the time 
course of changes. First, the samples were grouped into develop-
mental ages (<1 year neonates, 1–2 years infants, 3–4 years young 
children, 5–11 years older children, 12–20 years teens, 21–55 years 
young adults, and >55 years older adults) with three or more cases 
in each group and following the age groups used by Law et al. 
(2003) and Duncan et al. (2010). Group mean values and standard 
errors were calculated for each antibody and normalized to the 
mean level of expression for the youngest group. Second, we plot-
ted scattergrams for each antibody that included both the average 
expression level (black symbols) for each case and every point from 
all runs (gray symbols). To help describe the pattern of change 
in expression across the lifespan, a weighted average curve was 
fit to each scatter plots using the locally weighted least squares 
method at 50% (dotted lines). In addition, an exponential decay 
function (solid lines) was fit to the scattergrams when there was 
a clear monotonic increase or decrease in the expression across 
the lifespan. The goodness of fit was determined (R) and the time 
constant (τ) for the rise or fall of expression level was calculated 
from the exponential decay function. The age when adult levels 
were reached was defined as 3τ. This provides an objective measure, 
representing the age at which expression had reached 87.5% of 
their asymptotic level.
Four indices were calculated to quantify relative changes in 
expression levels of the GABAergic signaling components: matura-
tion of receptor composition {GABAAα1:GABAAα2 ([GABAAα1 − 
GABAAα2]/[GABAAα1  +  GABAAα2]);  GABAAα1:GABAAα3 
([GABAAα1  −  GABAAα3]/[GABAAα1  +  GABAAα3]);  changes 
in  pre-synaptic  production  versus  trafficking,  GAD65:VGAT 
([GAD65  −  VGAT]/[GAD65  +  VGAT]);  and  changes  in  pre- 
versus  post-synaptic  GABAergic  signaling,  GAD65:Gephyrin 
([GAD65 − Gephyrin]/[GAD65 + Gephyrin])}.
Statistical  comparisons  of  differences  in  expression  levels 
between the age groups were calculated using Kruskal–Wallis non-
parametric analysis of variance and planned pairwise comparisons 
using a Tukey’s HSD test (p < 0.05).
results
The tissue samples were collected over a range (4–23 h) of post-
mortem intervals and the first step was to determine if that interval 
affected expression of any of the GABAergic proteins. There were 
no significant correlations (p values >0.1) between postmortem 
interval and the expression level for any of the antibodies (GAD65, 
R = 0.26; GAD67, R = 0.08; VGAT, R = 0.20; GABAAα1, R = 0.04; 
GABAAα2, R = 0.25; GABAAα3, R = 0.17; Gephyrin, R = 0.17; CB1, 
R = 0.19).
changes In pre-synaptIc gabaergic coMponents
Expression levels of the two GABA synthesizing enzymes (GAD65 
and GAD67) were quantified in human V1 across the lifespan. 
GAD65 is the isoform that localizes in the axon terminals and is 
responsible for supplying the “on-demand” pool of GABA. GAD67 
is the isoform that is predominant in the cell body and supplies the 
basal pool of GABA (Feldblum et al., 1993; Esclapez et al., 1994 ). Frontiers in Cellular Neuroscience  www.frontiersin.org  June 2010  | Volume 4  | Article 16  |  4
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(p < 0.002). VGAT expression was highest in infants (<1 year) and 
pre-teens (5–11 years), and had about 32% less expression in adults 
(21–55 years; p < 0.02; Figures 2C,D).
To quantify changes in the balance between the mechanisms 
that produce and traffic GABA in the pre-synaptic terminal, we 
calculated an index of GAD65:VGAT expression. There were sig-
nificant changes in the balance between GAD65:VGAT across the 
lifespan (p < 0.0005). There was more VGAT expression in both 
young children (<11 years) and older adults (>55 years; Figure 3). 
In contrast, there was an abrupt switch to much more GAD65 dur-
ing the teenage (p < 0.02) and young adult years (p < 0.001). These 
shifts in the balance between GAD65 and VGAT indicate that the 
rate limiting component regulating GABA transmission changes 
across the lifespan (Figure 3).
post-synaptIc changes In gabaa receptors
Expression levels for three subunits of the ionotropic GABAA recep-
tor were quantified (GABAAα1, GABAAα2, GABAAα3). Each subu-
nit exhibited a unique developmental trajectory across the lifespan 
(Figure 4). Quantification of GABAAα1 expression in human V1 
FiGure 1 | Developmental changes in GAD65 (A,B) and GAD67 (C,D) 
expression in human visual cortex across the lifespan plotted relative to the 
youngest age group (<1 year) for the grouped means and scattergrams  
(• average expression for each case; • all runs). Example blots for each case are 
presented above the scattergrams (B,D). The arrow indicates the band that was 
quantified. A weighted average curve was fit to each scatter plots using the 
locally weighted least squares method at 50% (dotted line). GAD65 showed a 
significant change across the lifespan (Kruskal–Wallis, p < 0.0001) with 
progressive increase in expression levels into the teenage and adult years then a 
loss with aging (A,B). There was no change in expression levels of GAD67 across 
the lifespan (C,D). The lines above the histograms identify the groups that were 
significantly different (Tukey’s post hoc HSD, *p < 0.05, **p < 0.02, ***p < 0.001).
Expression levels of GAD67 did not change across the lifespan 
(Figures 1A,B). In contrast, developmental changes were found 
for GAD65 expression levels (p < 0.0002; Figures 1C,D). GAD65 
showed a progressive 60% increase in expression levels from early in 
life (<4 years) to the teenage and adult years (p < 0.05), with a slight 
decline into older adults (>55 years). The difference in the devel-
opmental trajectories of these two enzymes indicates that the basal 
pool of GABA is maintained across the lifespan, whereas the axonal 
pool has a time window of heightened production capacity.
To further examine how the pre-synaptic components of the 
GABAergic system change across the lifespan in human V1, we 
quantified the expression of two key inhibitory proteins, CB1 and 
VGAT (Figure 2). CB1 is a pre-synaptic receptor involved in modu-
lating GABA release (Hajos and Freund, 2002); over the lifespan 
there were significant changes in the expression of CB1 in human 
V1 (p < 0.0002). In infants (<1 year) and pre-teens (5–11 years), 
CB1 expression was high, but in young children (1–2 years), adults 
(21–55 years), and older adults (>55 years) it was about 40% less 
(p < 0.05; Figures 2A,B). The GABA vesicular transporter VGAT 
showed a similar pattern of expression levels across the lifespan Frontiers in Cellular Neuroscience  www.frontiersin.org  June 2010  | Volume 4  | Article 16  |  5
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FiGure 3 | The index of GAD65:VGAT (A,B) gives insight into the relative 
balance between production and trafficking of GABA. The balance is in favor 
of VGAT early (<11 years) and late (>55 years) in development, but there is much 
more GAD65 during the teenage to adult years (12–55 years) (Kruskal–Wallis, 
p < 0.0002) (A,B). The lines above the histograms identify the groups that were 
significantly different (Tukey’s post hoc HSD, *p < 0.05, **p < 0.02, 
***p < 0.001) (• average expression for each case; • all runs; dotted line is the 
weighted average).
FiGure 2 | Quantification of changes in expression levels of CB1 (A,B) and 
VGAT (C,D) in human visual cortex across the lifespan. The graphs follow the 
same conventions as described in Figure 1. CB1 levels are high in infants (<1 year) 
then fall into young children (1–2 years) before rising again in pre-teens (5–11 years) 
and falling again in teens (12–20 years) and leveling off (Kruskal–Wallis, p < 0.0001) 
(A,B). For VGAT 2 bands were quantified (arrows at 50 and 57 kDa). VGAT levels are 
highest in infants (<1 year) then gradually fall into children (3–4 years) before rising 
again into pre-teens (5–11 years) then falling into adults (21–55 years) before finally 
rising again in older adults (>55 years) (Kruskal–Wallis, p < 0.005) (C,D). The lines 
above the histograms identify the groups that were significantly different (Tukey’s 
post hoc HSD, *p < 0.05, **p < 0.02, ***p < 0.001) (• average expression for each 
case; • all runs; dotted line is the weighted average).Frontiers in Cellular Neuroscience  www.frontiersin.org  June 2010  | Volume 4  | Article 16  |  6
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immature subunits. To determine the magnitude and time course of 
receptor maturation we calculated two indices (GABAAα1:GABAAα2, 
GABAAα1:GABAAα3). The GABAAα1:GABAAα2 balance was ini-
tially in favor of GABAAα2, then progressively shifted toward more 
GABAAα1 (Figure 5). We fit a tau (τ) function to the index to 
quantify the time course of the switch in receptor composition. 
The mature balance was reached at 4.5 years of age (3τ, τ = 1.50 
years, R = 0.84; p < 0.0001; Figure 5B). The GABAAα1:GABAAα3 
switch was smaller in magnitude and much more abrupt. There 
was initially more GABAAα3, but that switched within the first year 
to slightly more GABAAα1, and reached mature levels at about 8 
months of age (3τ, τ = 0.23 years, R = 0.65; p < 0.0001; Figure 5D). 
showed a prolonged development profile, increasing about 75% to 
reach adult levels at 13.5 years of age (3τ, τ = 4.50 years, R = 0.67; 
p < 0.0001; Figure 4B). GABAAα2 expression changed in the oppo-
site direction and had a slightly more rapid developmental profile, 
decreasing by about 65% to reach adult levels at 10 years of age 
(3τ, τ = 3.34 years, R = 0.96; p < 0.0001; Figure 4D). GABAAα3 
had no significant change in expression levels across the lifespan 
(p > 0.36; Figures 4E,F).
The three GABAA receptor subunits that we quantified are clas-
sified into two categories, immature (GABAAα2, GABAAα3) and 
mature (GABAAα1), with the mature subunit conferring faster 
receptor decay times and great affinity for GABA compared with the 
FiGure 4 | Changes in expression of GABAA receptor subunits GABAAα1 
(A,B), GABAAα2 (C,D), and GABAAα3 (e,F) during postnatal development. 
An exponential decay function (solid line) was fit to the expression levels for 
GABAAα1 and GABAAα2 and the time constants (τ) were calculated with adult 
levels defined as 3τ. GABAAα1 expression increased until early teens when it 
leveled off (3τ = 13.5 years, τ = 4.50 years, R = 0.67; p < 0.0001; B). GABAAα2 
expression decreased until older childhood when it leveled off (3τ = 10 years of 
age, τ = 3.34 years, R = 0.96; p < 0.0001; D). GABAAα3 expression levels did not 
change significantly throughout the lifespan (e,F) (dotted line is the weighted 
average). The lines above the histograms identify the groups that were 
significantly different (Tukey’s post hoc HSD, *p < 0.05, **p < 0.02, 
***p < 0.001) (• average expression for each case; • all runs).Frontiers in Cellular Neuroscience  www.frontiersin.org  June 2010  | Volume 4  | Article 16  |  7
Pinto et al.  Human development of GABAergic mechanisms
switched to more Gephyrin during childhood (1–11 years of age), 
then a balance during the teenage and adult years, followed by an 
abrupt switch to relatively more GAD65 in older adults (p < 0.05; 
Figures 6C,D). These changes represent a shift in GABAergic signal-
ing mechanisms from more pre-synaptic, to more post-synaptic, to 
a balance, to substantially more pre-synaptic. This index captures 
an important aspect of the changing nature of the pre- and post-
synaptic GABAergic signaling mechanisms in human V1 across 
the lifespan. There is not a single balance that is maintained across 
the lifespan.
dIscussIon
Our study is the first to characterize changes in pre- and post-
synaptic components of the GABAergic signaling system across 
the lifespan in human primary visual cortex. We found a com-
plex pattern of different developmental trajectories among these 
GABAergic  signaling  mechanisms.  Many  of  the  changes  were 
prolonged and continued well into the teen, young adult, and 
even older adult years. For example, the peak of GAD65 expres-
sion was not reached until the teen to young adult years before 
Both indices showed a shift to more GABAAα1, however, there 
was a greater change for the shift from more GABAAα2 to more 
GABAAα1.
To examine the overall levels of GABAA receptors in human 
V1, we quantified the expression of Gephyrin across the lifespan. 
Gephyrin  is  the  GABAA  receptor  anchoring  protein  and  these 
expression levels provide an indication of total GABAA receptor 
expression. There were significant changes in Gephyrin expression 
across the lifespan (p < 0.002). Early in development (<1 year) and 
for older adults (>55 years), the expression levels for Gephyrin were 
low. In contrast, during the rest of the lifespan, Gephyrin expres-
sion was significantly higher (∼120% increase) and had a peak in 
expression during childhood (5–11 years; p < 0.05; Figure 6A).
pre- versus post-synaptIc developMent
To determine the relative contribution of pre- versus post-  synaptic 
components of GABAergic signaling across the lifespan, we cal-
culated a index of Gephyrin:GAD65 expression (Figure 6). In 
young infants (<1 year) this pre- versus post-synaptic balance was 
in favor of more GAD65, the pre-synaptic side (p < 0.01). This 
FiGure 5 | The indices of GABAAα1:GABAAα2 (A,B) and 
GABAAα1:GABAAα3 (C,D) are important for determining the kinetics and 
maturation of the GABAA receptor. The GABAAα1:GABAAα2 index starts in 
favor of GABAAα2, then shifts to more GABAAα1 in children (3–4 years), reaching 
the adult balance in younger childhood (3τ = 4.5 years of age, τ = 1.50 years, 
R = 0.84; p < 0.0001; B). The GABAAα1: GABAAα3 index starts out with more 
GABAAα3 very early, then quickly shifts to slightly more GABAAα1, reaching adult 
levels within the first year (3τ = 0.69 years of age, τ = 0.23 years, R = 0.65; 
p < 0.0001; D). The lines above the histograms identify the groups that were 
significantly different (Tukey’s post hoc HSD, *p < 0.05, **p < 0.02, 
***p < 0.001) (• average expression for each case; • all runs; solid lines are 
exponential decay functions).Frontiers in Cellular Neuroscience  www.frontiersin.org  June 2010  | Volume 4  | Article 16  |  8
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tuning of cortical receptive fields (Leventhal et al., 2003; Fagiolini 
et al., 2004), and visual perception (Betts et al., 2005; Edden et al., 
2009).
There is a heterogenous array of GABAergic neurons and circuits 
in primate visual cortex (Jones, 1993). The diversity of anatomical 
and physiological characteristics points to 14–19 different types 
of GABAergic neurons in the cortex (Gupta et al., 2000). They are 
spread across all layers of the cortex and in primate visual cortex 
the largest concentration is in layers II–III and IVa (Beaulieu et al., 
1992). The GABAA receptor is also very diverse. This pentameric 
receptor has at least 20 different subunits, including α, β, γ, σ, ε, θ, 
and π, that combine to make a very wide range of different GABAA 
receptors (Sieghart, 1995; Cherubini and Conti, 2001; Rudolph 
et al., 2001). GABAergic interneurons make connections onto spe-
cific compartments of cortical pyramidal neurons. Synapses con-
taining α-subunits are differentially distributed across pyramidal 
neurons with all types of α-subunits found at synapses on dendrites, 
α1 and α2 are also found on the soma, and only α2 is on the axon 
initial segment. This diversity of morphologies, receptor compo-
sitions, and connectivity patterns confers a wide range of specific 
  falling off in aging. Thus, the potential to produce the on-demand 
pool of GABA, which enables repeated waves of phasic inhibi-
tion and experience-dependent plasticity, must have a very long 
developmental time course in human visual cortex. Changes in 
expression of GABAAα1 and GABAAα2 subunits were also pro-
longed and increased or decreased, respectively, into the teenage 
years. Comparing the balance between these subunits, however, 
showed that the switch from relatively more GABAAα2 to more 
GABAAα1 occurred during childhood. This switch is important 
for understanding changes in GABAergic signaling, since it is the 
relative balance of the GABAA subunits that influences the shift to 
more phasic inhibition (Prenosil et al., 2006). The current results 
extend our previous study that focused on synaptic changes dur-
ing the first 5 years of life (Murphy et al., 2005). In addition, we 
found a number of changes in GABAergic signaling during aging. 
Gephyrin and GAD65 declined into aging, highlighting that there 
are both pre- and post-synaptic losses of GABAergic signaling in 
the aging visual cortex. The changes across the life span in expres-
sion of these components of GABA signaling undoubtedly affects 
experience-dependent plasticity (Hensch, 2005), development and 
FiGure 6 | Changes in expression of Gephyrin (A,B) and the index of 
Gephyrin:GAD65 (C,D) during postnatal development. Expression levels of 
Gephyrin are lowest in infants (<1 year) and older adults (<55 years) and higher 
for the rest of the lifespan (Kruskal–Wallis, p < 0.005) (A). The Gephyrin:GAD65 
index shows a shift from more GAD65 in infants (<1 year) to more Gephyrin in 
children (1–11 years) to a balance from the teenage to adult years (12–55) then a 
switch to much more GAD65 in aging (>55 years) (Kruskal–Wallis, p < 0.008) (C). 
The lines above the histograms identify the groups that were significantly 
different (Tukey’s post hoc HSD, *p < 0.05, **p < 0.02, ***p < 0.001) (• average 
expression for each case; • all runs; dotted line is the weighted average).Frontiers in Cellular Neuroscience  www.frontiersin.org  June 2010  | Volume 4  | Article 16  |  9
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trajectories that we describe reflect the average across the whole 
group of samples and this type of cross sectional design cannot 
address how the levels of these GABAergic markers change in an 
individual. The higher level of variability in expression that we 
found for older children through young adults suggests that the 
timing of rapid changes may vary across individuals.
The immunoblotting technique used for the current study does 
not allow for an analysis of developmental changes in the variety of 
different morphological types of GABAergic interneurons, specific 
intracortical inhibitory circuits, or locations of receptor subunits 
on different compartments of the post-synaptic neuron. It will be 
important for future studies to extend this work to include anatomi-
cal methods that describe and quantify laminar and morphologi-
cal changes in GABAergic neurons, as well as tracing the specific 
locations of GABAergic synapses in cortical circuits. These will be 
challenging studies because of the difficulty obtaining postmortem 
tissue that is both appropriate for anatomical investigations and 
covers a wide range of ages. Despite these obstacles they should be 
a priority, especially since site-specific optimization of GABA syn-
apses may trigger experience-dependent plasticity in visual cortex 
(Katagiri et al., 2007).
transItIonal stages In gabaergic sIgnalIng
The pattern of changes in expression of the GABAergic signaling 
mechanisms was complex and there was not one or two key com-
ponents driving these changes. Instead, each pre- and post-synaptic 
mechanisms followed different developmental trajectory that com-
bine to create a complex pattern of overall changes. The expres-
sion patterns for individual proteins can be characterized as either 
no change (GAD67, GABAAα3), a monotonic increase or decrease 
(GABAAα1, GABAAα2), a biphasic increase then decrease (GAD65, 
Gephyrin), or multiple increases and decreases (VGAT, CB1) across 
the lifespan. These different developmental trajectories may be linked 
to functional changes and the different roles that these synaptic pro-
teins play in GABAergic signaling. For example, the multiple increases 
and decreases found for CB1 may reflect the multiple roles that it 
has in synaptic development, plasticity, and regulating GABA release 
(Hajos and Freund, 2002). By calculating a series of indices to quantify 
the balance between the various pre- and post-synaptic GABAergic 
mechanisms, we found three transitional stages during early develop-
ment, teen years, or aging when there were large switches in the relative 
amounts of the components of the GABAergic signaling system. The 
three distinct transitional stages in GABAergic signaling reflect impor-
tant times during the lifespan when there must be significant changes 
in the function of GABAergic inhibition. Interestingly, these transition 
stages line up with time points when visual functions are changing and 
when the visual system is sensitive to experience-dependent change 
(Faubert, 2002; Lewis and Maurer, 2005; Maurer et al., 2007a,b).
The first stage reflects an early developmental transition between 
neonates/infants (<2 years) and young children (3–5 years) when 
there was a switch in composition of the GABAA receptor. The 
relative expression switched from more of the immature subunits 
(GABAAα2 and GABAAα3) to more of the mature (GABAAα1) 
subunit. The GABAAα1 subunit has a special role in development of 
the visual cortex driving experience-dependent plasticity whereas 
GABAAα2 modulates neuronal firing (Fagiolini et al., 2004). The 
kinetics  of  the  GABAA  receptor  speed  up  threefold  when  the 
functions to the different GABAergic circuits (Hensch, 2005). This 
heterogeneity poses a challenge for understanding the organization 
and function of GABAergic signaling.
The diversity in the GABAergic system introduces a number of 
sources of variability. We found substantial inter-individual vari-
ability for expression of the GABAergic proteins in human visual 
cortex and this probably reflects the heterogeneous nature of the 
GABAergic system. In addition, we also found substantial variability 
when measuring the expression levels of the GABAergic proteins from 
individuals. This measurement variability likely arises because the 
GABAergic system represents a smaller fraction of the total number 
of neurons and synapses in visual cortex compared to the excitatory 
system. This smaller sample size will contribute to increased meas-
urement variability when quantifying GABAergic expression. For 
example, GABAergic signaling in primate visual cortex comprises 
about 20% of the total number of neurons (Beaulieu et al., 1992; 
Jones, 1993), and an even smaller portion (17%) of the total number 
of synapses (Beaulieu et al., 1992). Based on the difference in propor-
tion of excitatory versus inhibitory synapses, statistics predicts that 
there should be about 4.8 times more measurement variability when 
quantifying expression of GABAergic synaptic proteins. This is very 
close to the larger measurement variability that we have found when 
quantifying the expression of inhibitory (gephyrin) versus excita-
tory (PSD-95) anchoring proteins in rat cortex (Pinto and Murphy, 
unpublished results). Additional variability in higher mammals will 
arise from inter-individual differences in the number of inhibitory 
synapses (Beaulieu and Colonnier, 1985), and the relatively smaller 
number of inhibitory synapses per neuron in primates compared 
with rats (Beaulieu et al., 1992). Taken together, the diversity and 
smaller proportion of GABAergic synapses predicts that there must 
be substantial variability when measuring expression of GABAergic 
synaptic proteins. Furthermore, previous studies suggest that there 
is greater synaptic specialization in non-human primates (Beaulieu 
et al., 1992) raising the possibility of even greater diversity in human 
cortex. In spite of these inherent sources of variability, our large data 
set makes it clear that there are significant changes in GABAergic 
expression in human visual cortex across the lifespan.
Monyer and Markram (2004) aptly describe studying GABAergic 
interneurons as a daunting task because of the diverse nature of 
this system. They also point out that combinatorial approaches 
are helping to clarify the diversity of GABAergic interneurons. 
In our study, we used a large number of samples from human 
visual cortex covering the lifespan to quantify the expression and 
developmental trajectories of eight components of the GABAergic 
system. The number of proteins quantified allowed us to capture 
a unique perspective on both pre- and post-synaptic development 
that would be missed by studying a smaller set of synaptic proteins. 
Furthermore, by quantifying the expression of GABAergic proteins 
in a preparation enriched for synaptic proteins (Hollingsworth 
et al., 1985; Titulaer and Ghijsen, 1997; Quinlan et al., 1999), we 
are able to tie the current findings closer to functional changes at 
the synapse. This is especially important for changes that affect 
experience-dependent plasticity (Quinlan et al., 1999). This con-
trasts with other approaches, such as measuring mRNA expression 
of GABAergic components (e.g., Duncan et al., 2010), because it 
is hard to make the link between mRNA expression and the level 
of protein expression at the synapse. Finally, the developmental Frontiers in Cellular Neuroscience  www.frontiersin.org  June 2010  | Volume 4  | Article 16  |  10
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lInks wIth experIence-dependent plastIcIty
Previous studies have shown that a specific excitatory-inhibitory 
balance and expression of the GABAAα1 subunit are required for 
ocular dominance plasticity in the developing rodent visual cortex 
(Hensch et al., 1998; Fagiolini et al., 2004). Furthermore, inhibition 
is abnormal in visual cortex of monocularly deprived (Burchfiel and 
Duffy, 1981) and strabismic cats (Singer et al., 1980). Our findings 
suggest that the period of ocular dominance plasticity in the human 
visual cortex is prolonged. If ocular dominance plasticity follows the 
development of GABAAα1 then it would extend through childhood 
into teenage and possibly even to young adult years. This idea is 
consistent with the prolonged period of visual changes found in 
children with cataracts (Lewis and Maurer, 2005; Maurer et al., 
2007a,b). Importantly, the current findings indicate that primary 
visual cortex continues to have the necessary balance of GABAergic 
signaling mechanisms to mediate experience-dependent plasticity 
well into the teenage years. In addition, because the development 
of GAD65 expression may extend into the young adult years it is 
possible that this affects plasticity in primary visual cortex and 
contributes to visual recovery promoted by perceptual learning 
treatment in adults with amblyopia (Levi and Li, 2009). Finally, 
the losses in aging may contribute to reduced synaptic plasticity 
and may be part of a more generalized change in the balance of 
synaptic proteins (Williams et al., 2010) in the aging cortex that 
could underlie age-related perceptual and cognitive declines.
The prolonged window of GABA changes in human visual cor-
tex provides an opportunity to translate experimental treatments 
that target GABAergic signaling in the visual system into thera-
peutics that may even be useful in treating amblyopia in young 
adults. For example, new studies have shown that fluoxetine can 
reinstate ocular dominance plasticity in the adult cortex by reducing 
intracortical inhibition (Maya Vetencourt et al., 2008; Harauzov 
et al., 2010). The current study provides the necessary information 
about GABAergic signaling in human cortex to begin the process of 
translating the exciting therapies being developed in animal models 
into effective treatments for amblyopia in humans.
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GABAAα1 subunit dominates (Gingrich et al., 1995) and gamma 
bursts depend on circuits dominated by GABAAα1 (Cardin et al., 
2009; Sohal et al., 2009). Furthermore, the switch has pharmaco-
logical implications as the α2 subunit exhibits the anxiolytic effects 
of benzodiazepines, whereas α1, α3, and α5 mediate the sedative 
and amnesic effects (Rudolph et al., 1999; Löw et al., 2000). This 
developmental switch in GABAA receptor subunits also occurs in 
rats (Bosman et al., 2002), cats (Chen et al., 2001), and macaque 
monkeys (Hendrickson et al., 1994). For these species, however, the 
switch is correlated with different aspects of the critical period. In 
rats, the switch occurs before the start of the critical period (Heinen 
et al., 2004), but in cats and macaque monkeys the switch overlaps 
the critical period for ocular dominance plasticity (Hendrickson 
et al., 1994; Chen et al., 2001). The current results show that in 
human V1 this transitional switch in expression of GABAA receptor 
subunits spans the critical period, when disrupting vision can cause 
long lasting changing in visual acuity (Lewis and Maurer, 2005). 
Perhaps this first stage defines the period of ocular dominance 
plasticity in human V1.
In the second stage, the teenage transition was a switch from a 
greater capacity for trafficking GABA (more VGAT) to a greater capac-
ity to produce the on-demand pool of GABA (more GAD65). In addi-
tion, there was a high level of GABAAα1 expression during this stage. 
These suggest that in teens and young adults the pool of on-demand 
GABA can be readily replenished and binds with α1 containing recep-
tors to maintain a high level of phasic inhibition. Perhaps this combi-
nation is needed for optimal coding of neural signals, especially during 
periods of sustained neural activity. Optimal orientation tuning of 
receptive fields (Leventhal et al., 2003) and perceptual performance 
on orientation discrimination (Edden et al., 2009) depend on the 
level of GABA concentration. It seems likely that the high levels of 
GAD65 and GABAAα1 at this stage are contributing to optimal visual 
performance on tasks such as orientation discrimination.
In the third stage, during the transition to older adults, there were 
two switches in the balance between components of the GABAergic 
signaling system: from greater capacity to produce GABA (more 
GAD65) to greater capacity to traffic GABA to the synapse (more 
VGAT); and from relatively more post-synaptic (more Gephyrin) to 
more pre-synaptic (more GAD65) expression. Both of these changes 
were large switches from those found for young adults and point 
to significant changes in functioning of GABAergic synapses in the 
aging visual cortex. Furthermore, the time course of the GABAergic 
changes in aging is similar to the decline of visual abilities. The 
changes could contribute to the loss of orientation tuning (Leventhal 
et al., 2003) and processing of complex visual stimuli that are partic-
ularly vulnerable during aging (Habak and Faubert, 2000; Faubert, 
2002). For example, the perception of a moving stimulus in the Frontiers in Cellular Neuroscience  www.frontiersin.org  June 2010  | Volume 4  | Article 16  |  11
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